✦ LIBER ✦

Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China

✍ Scribed by Rong Cheng Li; Feng Xiang Li; Yan Ping Li; Qi Ming Hou; Chang Gui Li; Ya Nan Li; Fu Sheng Chen; Xue Zhong Hu; Wen Bin Su; Shu Min Zhang; Han Hua Fang; Qiang Ye; Tian De Zeng; Tao Xuan Liu; Xiu Bi Li; Yun Neng Huang; Man Ling Deng; Yan Ping Zhang; Esteban Ortiz

Book ID: 116963403
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 295 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.12.103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a hexavalen

Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age

✍ Scott A. Halperin; Bruce Tapiero; Francisco Diaz-Mitoma; Barbara J. Law; Agnes H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Safety, reactogenicity and immunogenicit

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

✍ F Zepp; M Knuf; U Heininger; K Jahn; A Collard; P Habermehl; L Schuerman; R Säng 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Safety and immunogenicity of three diffe

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age

✍ Francisco Diaz-Mitoma; Scott A. Halperin; Bruce Tapiero; Agnes Hoffenbach; Pamel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Immunogenicity and safety of a combined

Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles–mumps–rubella or a diphtheria–tetanus–acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12–18 months

✍ V. Usonis; S. Meriste; V. Bakasenas; I. Lutsar; F. Collard; M. Stoffel; N. Torni 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 102 KB

An Acellular Pertussis, Diphtheria, Teta

An Acellular Pertussis, Diphtheria, Tetanus, Inactivated Poliovirus, Hib-Conjugate Combined Vaccine (Pentaxim) at 2, 4, and 6 Months of Age Plus Hepatitis B at Birth, 2, and 6 Months of Age in Infants in Thailand

✍ U. Thisyakorn; T. Chotpitayasunondh; C. Pancharoen; S. Chuenkitmongkol; E. Ortiz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Assessment of the immunogenicity and rea

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2, 4 and 6 months of age

✍ Javier Arístegui; Rafael Dal-Ré; Elisa Garrote; Antonio González; Juan-Pedro Arr 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 802 KB